This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday
Author: Avi Kapoor | August 04, 2025 07:47am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
JP Morgan analyst Brian Cheng downgraded the rating for Allogene Therapeutics, Inc. (NASDAQ:ALLO) from Overweight to Neutral. Allogene Therapeutics shares closed at $1.08 on Friday. See how other analysts view this stock.
Piper Sandler analyst Alexander Goldfarb downgraded AvalonBay Communities, Inc. (NYSE:AVB) from Overweight to Neutral and cut the price target from $255 to $200. AvalonBay Communities shares closed at $184.44 on Friday. See how other analysts view this stock.
Wolfe Research analyst Andy Chen downgraded the rating for Vera Therapeutics, Inc. (NASDAQ:VERA) from Outperform to Peer Perform. Vera Therapeutics shares closed at $20.95 on Friday. See how other analysts view this stock.
HSBC analyst Kim Fustier downgraded Shell plc (NYSE:SHEL) from Buy to Hold and lowered the price target from $78.9 to $78.3. Shell shares closed at $72.00 on Friday. See how other analysts view this stock.
Considering buying AVB stock? Here’s what analysts think:
